BCL2 and acute myeloid leukemia: To determine if TI and NK cells in AML can affect the expression of Bax and Bcl-2 proteins, the inhibitory impacts of both single and combined treatments with NK cells and TI were assessed on the protein levels of Kg-1a and primary AML cells using an ELISA assay (Fig. 6).